Apocynin: Chemical and biophysical properties of a NADPH oxidase inhibitor

Molecules

Volumn 18, Issue 3, 2013, Pages 2821-2839

  Petrônio, Maicon S ^a   Zeraik, Maria Luiza ^a   Da Fonseca, Luiz Marcos ^a   Ximenes, Valdecir F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Albumin; Apocynin; Binding constant; Hydrogen peroxide; NADPH oxidase

Indexed keywords

ACETOPHENONE DERIVATIVE; APOCYNIN; ENZYME INHIBITOR; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER;

ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG ANTAGONISM; KINETICS; OXIDATION REDUCTION REACTION; PH;

ACETOPHENONES; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPOCHLOROUS ACID; KINETICS; NADPH OXIDASE; OXIDATION-REDUCTION;

EID: 84875625176     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18032821     Document Type: Article

References (47)

1. Kleniewska, P.; Piechota, A.; Skibska, B.; Gora̧ca, A. The NADPH oxidase family and its inhibitors. Arch. Immunol. Ther. Exp. (Warsz) 2012, 60, 277-294.
2. Katsuyama, M.; Matsuno, K.; Yabe-Nishimura, C. Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme. J. Clin. Biochem. Nutr. 2012, 50, 9-22.
3. Nauseef, W.M. Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 2008, 283, 16961-16965.
4. Stolk, J.; Hiltermann, T.J.; Dijkman, J.H.; Verhoeven, A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 1994, 11, 95-102.
5. Riganti, C.; Costamagna, C.; Bosia, A.; Ghigo, D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharmacol. 2006, 212, 179-187.
6. Vejrazka, M.; Mícek, R.; Stípek, S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim. Biophys. Acta 2005, 1722, 143-147.
7. Schlüter, T.; Steinbach, A.C.; Steffen, A.; Rettig, R.; Grisk, O. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardiovasc. Res. 2008, 80, 271-279.
8. Heumuller, S.; Wind, S.; Barbosa-Sicard, E.; Schmidt, H.H.; Busse, R.; Schroder, K.; Brandes, R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51, 211-217.
9. Aldieri, E.; Riganti, C.; Polimeni, M.; Gazzano, E.; Lussiana, C.; Campia, I.; Ghigo, D. Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr. Drug Metab. 2008, 9, 686-96.
10. Liu, Y.N.; Davidson, B.P.; Yue, Q.; Belcik, T.; Xie, A.; Inaba, Y.; McCarty, O.J.; Tormoen, G.W.; Zhao, Y.; Ruggeri, Z.M.; et al. Molecular Imaging of Inflammation and Platelet Adhesion in Advanced Atherosclerosis: Effects of Antioxidant Therapy with NADPH Oxidase Inhibition. Circ. Cardiovasc. Imaging 2012, 6, 74-82.
11. Li, J.; Yang, J.Y.; Yao, X.C.; Xue, X.; Zhang, Q.C.; Wang, X.X.; Ding, L.L.; Wu, C.F. Oligomeric Aβ-Induced Microglial Activation is Possibly Mediated by NADPH Oxidase. Neurochem. Res. 2012, 38,443-452.
12. Chen, Q.Z.; Han, W.Q.; Chen, J.; Zhu, D.L.; Chen, Y.; Gao, P.J. Anti-stiffness effect of apocynin in deoxycorticosterone acetate-salt hypertensive rats via inhibition of oxidative stress. Hypertens. Res. 2012, doi:10.1038/hr.2012.170.
13. Ghosh, A.; Kanthasamy, A.; Joseph, J.; Anantharam, V.; Srivastava, P.; Dranka, B.P.; Kalyanaraman, B.; Kanthasamy, A.G. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. J. Neuroinflammation 2012, 9, 241.
14. Li, M.; Zhuan, L.; Wang, T.; Rao, K.; Yang, J.; Yang, J.; Quan, W.; Liu, J.; Ye, Z. Apocynin Improves Erectile Function in Diabetic Rats through Regulation of NADPH Oxidase Expression. J. Sex. Med. 2012, 9, 3041-3050.
15. Seo, J.S.; Park, J.Y.; Choi, J.; Kim, T.K.; Shin, J.H.; Lee, J.K.; Han, P.L. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J. Neurosci. 2012, 32, 9690-9699.
16. Stefanska, J.; Sarniak, A.; Wlodarczyk, A.; Sokolowska, M.; Doniec, Z.; Bialasiewicz, P.; Nowak, D.; Pawliczak, R. Hydrogen peroxide and nitrite reduction in exhaled breath condensate of COPD patients. Pulm. Pharmacol. Ther. 2012, 25, 343-348.
17. Johnson, D.K.; Schillinger, K.L.; Kwait, D.M.; Hughes, C.V.; McNamara, E.J.; Ishmael, F.; O'Donnell, R.W.; Chang, M.M.; Hogg, M.G.; Dordick, J.S.; et al. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 2002, 9, 191-203.
18. Li, M.; Liu, Z.; Zhuan, L.; Wang, T.; Guo, S.; Wang, S.; Liu, J.; Ye, Z. Effects of apocynin on oxidative stress and expression of apoptosis-related genes in testes of diabetic rats. Mol. Med. Rep. 2012, doi:10.3892/mmr.2012. 1132.
19. Hur, J.; Lee, P.; Kim, M.J.; Kim, Y.; Cho, Y.W. Ischemia-activated microglia induces neuronal injury via activation of gp91phox NADPH oxidase. Biochem. Biophys. Res. Commun. 2010, 391, 1526-1530.
20. Ximenes, V.F.; Kanegae, M.P.; Rissato, S.R.; Galhiane, M.S. The oxidation of apocynin catalyzed by myeloperoxidase: Proposal for NADPH oxidase inhibition. Arch. Biochem. Biophys. 2007, 457, 134-141.
21. Kanegae, M.P.; Condino-Neto, A.; Pedroza, L.A.; de Almeida, A.C.; Rehder, J.; da Fonseca, L.M.; Ximenes, V.F. Diapocynin versus apocynin as pretranscriptional inhibitors of NADPH oxidase and cytokine production by peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 2010, 393, 551-554.
22. Mora-Pale, M.; Weïwer, M.; Yu, J.; Linhardt, R.J.; Dordick, J.S. Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorg. Med. Chem. 2009, 17, 5146-5152.
23. Masella, R.; Santangelo, C.; D'Archivio, M.; LiVolti, G.; Giovannini, C.; Galvano, F. Protocatechuic acid and human disease prevention: Biological activities and molecular mechanisms. Curr. Med. Chem. 2012, 19, 2901-2917.
24. Sedeh, I.F.; Ohman, L.O.; Sjoberg, S. Equilibrium and structural studies of silicon(IV) and aluminum(III) in aqueous-solution. Aqueous complexation between silicic-acid and some ortho-diphenolic and triphenolic compounds. Acta Chem. Scand. 1992, 46, 933-940.
25. Ghose, A.K.; Crippen, G.M. Atomic physicochemical parameters for threedimensional-structuredirected quantitative structureactivity relationships. Modeling dispersive and hydrophobic interactions. J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
26. Laguerre, M.; López-Giraldo, L.J.; Lecomte, J.; Baréa, B.; Cambon, E.; Tchobo, P.F.; Barouh, N.; Villeneuve, P. Conjugated autoxidizable triene (CAT) assay: A novel spectrophotometric method for determination of antioxidant capacity using triacylglycerol as ultraviolet probe. Anal. Biochem. 2008, 380, 282-290.
27. Van den Worm, E.; Beukelman, C.J.; van den Berg, A.J.; Kroes, B.H.; Labadie, R.P.; van Dijk, H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur. J. Pharmacol. 2001, 433, 225-230.
28. De Faria, C.M.; Nazaré, A.C.; Petrônio, M.S.; Paracatu, L.C.; Zeraik, M.L.; Regasini, L.O.; Silva, D.H.; da Fonseca, L.M.; Ximenes, V.F. Protocatechuic acid alkyl esters: Hydrophobicity as a determinant factor for inhibition of NADPH oxidase. Curr. Med. Chem. 2012, 19, 4885-4893.
29. Castro, M.C.; Francini, F.; Schinella, G.; Caldiz, C.I.; Zubiría, M.G.; Gagliardino, J.J.; Massa, M.L. Apocynin administration prevents the changes induced by a fructose-rich diet on rat liver metabolism and the antioxidant system. Clin. Sci. (Lond.) 2012, 123, 681-692.
30. Fanali, G.; di Masi, A.; Trezza, V.; Marino, M.; Fasano, M.; Ascenzi, P. Human serum albumin: From bench to bedside. Mol. Aspects Med. 2012, 33, 209-290.
31. Lakowicz, J.R. Principles of Fluorescence Spectroscopy, 3rd ed.; Springer: New York, NY, USA, 2006.
32. Lakowicz, J.R.; Weber, G. Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules. Biochemistry 1973, 12, 4161-4170.
33. Naik, P.N.; Chimatadar, S.A.; Nandibewoor, S.T. Interaction between a potent corticosteroid drug - Dexamethasone with bovine serum albumin and human serum albumin: A fluorescence quenching and fourier transformation infrared spectroscopy study. J. Photochem. Photobiol. B 2010, 100, 147-159.
34. Xu, Q.; Liu, Q.; Zuo, Y.; Bi, Y.; Gao, S. Spectroscopic Studies on the Interaction of Vitamin C with Bovine Serum Albumin. J. Solution Chem. 2012, 38, 15-25.
35. Chen, T.; Cao, H.; Zhu, S.; Lu, Y.; Shang, Y.; Wang, M.; Tang, Y.; Zhu, L. Investigation of the binding of Salvianolic acid B to human serum albumin and the effect of metal ions on the binding. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2011, 81, 645-652.
36. Zhu, S.; Liu, Y. Spectroscopic analyses on interaction of Naphazoline hydrochloride with bovine serum albumin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2012, 98, 142-147.
37. Burstein, E.A.; Vedenkina, N.S.; Ivkova, M.N. Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol. 1973, 18, 263-279.
38. Ni, Y.; Su, S.; Kokot, S. Spectrofluorimetric studies on the binding of salicylic acid to bovine serum albumin using warfarin and ibuprofen as site markers with the aid of parallel factor analysis. Anal. Chim. Acta 2006, 580, 206-215.
39. Muller, N.; Lapicque, F.; Drelon, E.; Netter, P. Binding sites of fluorescent probes on human serum albumin. J. Pharm. Pharmacol. 1994, 46, 300-304.
40. Ximenes, V.F.; Paino, I.M.; Faria-Oliveira, O.M.; Fonseca, L.M.; Brunetti, I.L. Indole ring oxidation by activated leukocytes prevents the production of hypochlorous acid. Braz. J. Med. Biol. Res. 2005, 38, 1575-1583.
41. Ximenes, V.F.; Maghzal, G.J.; Turner, R.; Kato, Y.; Winterbourn, C.C.; Kettle, A.J. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem. J. 2009, 425, 285-293.
42. Pace, C.N.; Vajdos, F.; Fee, L.; Grimsley, G.; Gray, T. How to measure and predict the molar absorption coefficient of a protein. Protein. Sci. 1995, 4, 2411-2423.
43. Zeraik, M.L.; Ximenes, V.F.; Regasini, L.O.; Dutra, L.A.; Silva, D.H.; Fonseca, L.M.; Coelho, D.; Machado, S.A.; Bolzani, V.S. 4'-aminochalcones as novel inhibitors of the chlorinating activity of myeloperoxidase. Curr. Med. Chem. 2012, 19, 5405-5413.
44. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. Lebensm. Wiss. Technol. 1995, 28, 25-30.
45. Singh, R.; Singh, N.; Saini, B.S.; Rao, H.S. In vitro antioxidant activity of pet ether extract of black pepper. Indian J. Pharmacol. 2008, 40, 147-151.
46. Roy, S. Fluorescence quenching methods to study protein-nucleic acid interactions. Methods Enzymol. 2004, 379, 175-187.
47. Chen, F.; Haigh, S.; Barman, S.; Fulton, D.J. From form to function: The role of Nox4 in the cardiovascular system. Front. Physiol. 2012, 3, 1-12.